Thipprapai Mahasaksiri

Thipprapai Mahasaksiri

Auto-generated profile, based on publicly available information

Thipprapai Mahasaksiri


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
KCKumutnart Chanprapaph
Kumutnart Chanprapaph
TMThipprapai Mahasaksiri
Thipprapai Mahasaksiri
CKChaninan Kositkuljorn
Chaninan Kositkuljorn
KLKanchana Leerunyakul
Kanchana Leerunyakul
PSPoonkiat Suchonwanit
Poonkiat Suchonwanit
Background: Increased rates of autoimmune diseases (ADs) have been reported in association with alopecia areata (AA); however, the risk factors for coexisting ADs in AA patients have been poorly investigated. Objective: To evaluate the prevalence and factors associated with AD comorbidities in patients with AA. Methods: This case–control study included patients diagnosed with AA between January 2000 and March 2020. Individuals with AA, both with and without concomitant ADs, were statistically compared. Variables significantly associated with coexisting ADs were identified using univariate and multivariate logistic regression analyses. Multinomial logistic regression analysis was performed to identify the specific risk factors for each concomitant AD. Results: Among the 615 patients with AA, comorbid ADs were found in 76 (12.4%). Autoimmune thyroid disease (AITD) exhibited the highest frequency (n = 42, 6.8%), followed by vitiligo (n = 15, 2.4%), and systemic lupus erythematosus (SLE) (n = 12, 2.0%). Logistic regression analyses revealed that female sex (odds ratio [OR] = 2.45, 95% confidence interval [CI] = 1.24– 4.82; P = 0.011), nail abnormalities (OR = 2.49, 95% CI = 1.14– 5.46; P = 0.023), and atopic diseases (OR = 1.98, 95% CI = 1.09– 2.43; P < 0.001) were significantly associated with coexisting ADs. Regarding each concomitant AD, nail abnormalities were an associated factor for AITD (OR = 4.65, 95% CI = 1.96– 7.24; P = 0.01), whereas coexisting atopic diseases were demonstrated as a predictor of vitiligo (OR = 2.48, 95% CI = 1.43– 4.58; P = 0.02). Female sex (OR = 1.61, 95% CI = 1.18– 4.27; P = 0.04) and family history of AD (OR = 1.85, 95% CI = 1.26– 4.19; P = 0.03) were predictors of SLE. Conclusion: This study suggests that female AA patients with nail abnormalities and atopic diseases have increased rates of AD comorbidities. A thorough review of systems for associated factors can help physicians screen for concomitant ADs.